Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Sigma Healthcare Limited (S5YA.F)

Compare
1.6300
0.0000
(0.00%)
As of 8:08:31 AM GMT+2. Market Open.
Loading Chart for S5YA.F
  • Previous Close 1.6300
  • Open 1.6300
  • Bid 1.6400 x --
  • Ask 1.7200 x --
  • Day's Range 1.6300 - 1.6300
  • 52 Week Range 0.6500 - 1.9400
  • Volume 6,600
  • Avg. Volume 688
  • Market Cap (intraday) 19.369B
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Mar 20, 2025
  • Forward Dividend & Yield 0.01 (0.38%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est --

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.

www.sigmahealthcare.com.au

--

Full Time Employees

January 31

Fiscal Year Ends

Recent News: S5YA.F

View More

Performance Overview: S5YA.F

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

S5YA.F
3.82%
S&P/ASX 200 [XJO] (^AXJO)
4.17%

1-Year Return

S5YA.F
118.63%
S&P/ASX 200 [XJO] (^AXJO)
2.81%

3-Year Return

S5YA.F
456.97%
S&P/ASX 200 [XJO] (^AXJO)
3.93%

5-Year Return

S5YA.F
414.20%
S&P/ASX 200 [XJO] (^AXJO)
42.49%

Compare To: S5YA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: S5YA.F

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    19.37B

  • Enterprise Value

    19.43B

  • Trailing P/E

    --

  • Forward P/E

    60.98

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.93

  • Price/Book (mrq)

    40.02

  • Enterprise Value/Revenue

    7.08

  • Enterprise Value/EBITDA

    624.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.09%

  • Return on Assets (ttm)

    0.71%

  • Return on Equity (ttm)

    -0.32%

  • Revenue (ttm)

    3.48B

  • Net Income Avi to Common (ttm)

    -3M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    234.16M

  • Total Debt/Equity (mrq)

    15.79%

  • Levered Free Cash Flow (ttm)

    453.7M

Research Analysis: S5YA.F

View More

Company Insights: S5YA.F

Research Reports: S5YA.F

View More

People Also Watch